CN110713977B - 一种cd8 t细胞的培养扩增方法 - Google Patents
一种cd8 t细胞的培养扩增方法 Download PDFInfo
- Publication number
- CN110713977B CN110713977B CN201810765305.XA CN201810765305A CN110713977B CN 110713977 B CN110713977 B CN 110713977B CN 201810765305 A CN201810765305 A CN 201810765305A CN 110713977 B CN110713977 B CN 110713977B
- Authority
- CN
- China
- Prior art keywords
- cells
- cd8t
- cell
- k3ec
- cd8t cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2307—Interleukin-7 (IL-7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2315—Interleukin-15 (IL-15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/515—CD3, T-cell receptor complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/30—Coculture with; Conditioned medium produced by tumour cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810765305.XA CN110713977B (zh) | 2018-07-12 | 2018-07-12 | 一种cd8 t细胞的培养扩增方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810765305.XA CN110713977B (zh) | 2018-07-12 | 2018-07-12 | 一种cd8 t细胞的培养扩增方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110713977A CN110713977A (zh) | 2020-01-21 |
CN110713977B true CN110713977B (zh) | 2022-05-27 |
Family
ID=69209145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810765305.XA Active CN110713977B (zh) | 2018-07-12 | 2018-07-12 | 一种cd8 t细胞的培养扩增方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110713977B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021533759A (ja) * | 2018-08-10 | 2021-12-09 | ユーティレックス カンパニー リミテッド | 癌抗原特異的cd8+t細胞を調製および凍結保存するための方法 |
WO2020032780A1 (ko) * | 2018-08-10 | 2020-02-13 | 주식회사 유틸렉스 | 암항원 특이적 세포독성 t세포 |
CN113512529B (zh) * | 2021-07-21 | 2022-11-25 | 上海赛傲生物技术有限公司 | 特异性抗病毒过继免疫细胞ab的制备方法 |
CN113981031A (zh) * | 2021-11-01 | 2022-01-28 | 山西中医药大学 | 一种新型t细胞功能检测方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102988959A (zh) * | 2004-04-05 | 2013-03-27 | 加利福尼亚大学董事会 | Nkg2d的调节 |
CN105112370A (zh) * | 2015-08-25 | 2015-12-02 | 深圳市科晖瑞生物医药有限公司 | 一种体外刺激外周血γδT细胞高效增殖的方法及其应用 |
-
2018
- 2018-07-12 CN CN201810765305.XA patent/CN110713977B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102988959A (zh) * | 2004-04-05 | 2013-03-27 | 加利福尼亚大学董事会 | Nkg2d的调节 |
CN105112370A (zh) * | 2015-08-25 | 2015-12-02 | 深圳市科晖瑞生物医药有限公司 | 一种体外刺激外周血γδT细胞高效增殖的方法及其应用 |
Non-Patent Citations (1)
Title |
---|
Cognate CD4 T-Cell Licensing of Dendritic Cells Heralds AntiCytomegalovirus CD8 T-Cell Immunity after Human Allogeneic Umbilical Cord Blood Transplantation;T. W. H. Flinsenberg et al.;《Journal of Virology》;20141105;摘要和材料与方法 * |
Also Published As
Publication number | Publication date |
---|---|
CN110713977A (zh) | 2020-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7470640B2 (ja) | T細胞を製造する方法 | |
JP6630074B2 (ja) | 新規に単離された細胞の治療組成物の操作および送達 | |
JP2021113200A (ja) | 能動的細胞免疫療法のためのサイトカイン組成物を用いたリンパ球の増殖 | |
EP1812563B1 (en) | Methods of generating antigen-specific cd4+cd25+ regulatory t cells, compositions and methods of use | |
KR102479118B1 (ko) | 보편적인 살해 t-세포 | |
CN110713977B (zh) | 一种cd8 t细胞的培养扩增方法 | |
JP2022065022A (ja) | 改変ヒト初代血液樹状細胞株を生成するための方法 | |
KR100895231B1 (ko) | 세포상해성 림프구의 제조방법 | |
JP2009504151A (ja) | 記憶Tリンパ球の視覚化、単離および遺伝子改変のための共通γ鎖サイトカインの使用 | |
KR20230017194A (ko) | 키메라 항원 수용체를 발현하는 바이러스 특이적 면역 세포를 사용한 동종반응의 치료 및 예방 | |
WO2015113140A1 (en) | Methods and compositions for producing a cell expressing a t cell receptor | |
WO2005077048A2 (en) | Immune modulation by regulating expression of the “minor” gene in immune dendritic cells | |
JP2022500038A (ja) | 癌免疫療法用mr1制限t細胞受容体 | |
JP2018512154A (ja) | キメラタンパク質 | |
US20220381772A1 (en) | Systems and methods for evaluating nk cells | |
CA3107515A1 (en) | Method for tumor treatment with immune effector cells | |
Plantinga et al. | Clinical grade production of wilms’ tumor-1 loaded cord blood-derived dendritic cells to prevent relapse in pediatric AML after cord blood transplantation | |
TW201245224A (en) | Cytotoxic t cell inducing composition | |
US20220056101A1 (en) | Anti-lmp2 tcr-t cell therapy for the treatment of ebv-associated cancers | |
US20070128670A1 (en) | Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and use thereof | |
CN111683971A (zh) | 医药重组受体组成物及方法 | |
WO2023249071A1 (ja) | T細胞受容体 | |
KR20210141599A (ko) | Cd28 t 세포의 배양액, 조성물 및 그 사용 방법 | |
WO2022232797A2 (en) | Virus-specific immune cells expressing chimeric antigen receptors | |
EA045289B1 (ru) | Способ получения т-клеток |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 200333 4th floor, building 15, Lane 879, Zhongjiang Road, Putuo District, Shanghai Patentee after: SHANGHAI ICELL BIOTECHNOLOGY Co.,Ltd. Patentee after: Chongqing Saiao Biotechnology Co.,Ltd. Patentee after: Beijing victory Biotechnology Co.,Ltd. Patentee after: Guangzhou victory Biotechnology Co.,Ltd. Patentee after: Xuzhou cell Medical Co.,Ltd. Address before: 200333 4th floor, building 15, Lane 879, Zhongjiang Road, Putuo District, Shanghai Patentee before: SHANGHAI ICELL BIOTECHNOLOGY Co.,Ltd. Patentee before: Chongqing United Stem Cell Technology Co.,Ltd. Patentee before: Beijing victory Biotechnology Co.,Ltd. Patentee before: Guangzhou victory Biotechnology Co.,Ltd. Patentee before: Xuzhou cell Medical Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Culture and Amplification Method for CD8 T Cells Effective date of registration: 20230717 Granted publication date: 20220527 Pledgee: Industrial Bank Co.,Ltd. Shanghai Changning sub branch Pledgor: SHANGHAI ICELL BIOTECHNOLOGY Co.,Ltd.|Guangzhou victory Biotechnology Co.,Ltd.|Chongqing Saiao Biotechnology Co.,Ltd.|Beijing victory Biotechnology Co.,Ltd.|Xuzhou cell Medical Co.,Ltd. Registration number: Y2023310000379 |